Clinical Trials on HPV Vaccine in Finland

Total 299 results

Pfizer

Completed

Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age

Meningococcal Vaccine

Finland, Spain, Poland
Helsinki University Central Hospital
University of Helsinki

Recruiting

Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Cholera | Typhoid Fever | Vaccine-Preventable Diseases

Finland
Pfizer

Completed

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Meningococcal Vaccine

Spain, Germany, Finland, Czechia, Poland, Denmark, Sweden
Pfizer

Completed

A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.

Meningococcal Vaccine

United States, Finland, Czechia, Poland
Pfizer

Completed

A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

Meningococcal Vaccine

United States, Canada, Finland, Italy, Poland, United Kingdom, Czech Republic, Germany
IDeA States Pediatric Clinical Trials Network
National Institutes of Health (NIH); University of Nebraska; University of Montana

Active, not recruiting

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool (MoVeUP)

Telemedicine | Pediatric ALL | Vaccine Hesitancy | COVID-19 Vaccines

United States
Lars Rombo

Completed

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Response to Hepatitis A Vaccine

Finland, Sweden
Vaxcyte, Inc.

Completed

Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults

Pneumococcal Vaccines

United States
Pfizer

Completed

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Vaccines | Meningococcal Vaccines

United States
Pfizer

Completed

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Vaccines | Meningococcal Vaccines

United States
Vaxcyte, Inc.

Active, not recruiting

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

Pneumococcal Vaccines

United States
Pfizer

Completed

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Meningitis | Meningococcal Vaccine | rLP2086 | Repevax | N Meningitidis Serogroup B

Germany, Finland, Poland
Jussi Sutinen
Helsinki University Central Hospital; University of Helsinki

Active, not recruiting

The Effect Tenofovir Disoproxil Fumarate (TDF) and Tenofovir Alafenamide (TAF) on Small Intestine Gut Wall (TENENTOX)

HIV Infections | Weight Gain

Finland
Helsinki University Central Hospital
Merck Sharp & Dohme LLC

Completed

Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir (OBERAL)

Fatty Liver | Metabolic Syndrome | HIV Seropositivity

Finland
Women and Infants Hospital of Rhode Island
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Strength for U in Relationship Empowerment (SURE)

Mental Health | IPV | Perinatal

United States
Brown University

Completed

A Peer Navigator Model to Improve Quit Attempts and Smoking Cessation Rates Among HIV-positive Smokers (P-NAV)

HIV

United States
Butler Hospital
Brown University

Completed

Engaging HIV Patients in Primary Care by Promoting Acceptance (HIV Engage)

HIV

United States
Brown University

Completed

Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing ((eTEST))

HIV

United States
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus | Rotavirus Vaccines

United States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
Brown University

Recruiting

Health Effects of the Standardized Research E-Cigarette in Smokers With HIV Smokers With HIV (ProjectSREC)

HIV

United States
Butler Hospital
Women and Infants Hospital of Rhode Island

Completed

The Health Check-Up for Expectant Moms

HIV

United States
Rhode Island Hospital
National Institute of Mental Health (NIMH)

Completed

Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth (ITP)

HIV Prevention

United States
Rhode Island Hospital

Unknown

Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos

HIV | AIDS

United States
University of California, San Francisco
Kenya Medical Research Institute; Organic Health Response; Microclinic International

Completed

The Kanyakla Study: a Microclinic Social Network Intervention for Promoting Engagement and Retention in HIV Care

HIV

Kenya
University of California, San Francisco
Kenya Medical Research Institute; Organic Health Response; Microclinic International

Completed

Mfangano Island Healthy Networks Impact Study (MIHNIS)

HIV

Kenya
Rhode Island Hospital
National Institute on Drug Abuse (NIDA)

Completed

Reducing HIV Risk Among Pregnant Women in Drug Treatment

HIV Risk Behavior

United States
The Miriam Hospital

Completed

mHealth Intervention Supporting HIV Treatment Adherence and Retention

HIV | Adherence | Retention

United States
GlaxoSmithKline

Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Infections, Papillomavirus | Papillomavirus Vaccines

United States
Brown University
National Cancer Institute (NCI)

Recruiting

Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts

Tobacco Use Cessation

United States
Rhode Island Hospital

Completed

A Multilevel Gaming Intervention for Persons on PrEP

PrEP | HIV Risk | MSM

United States
Rhode Island Hospital

Completed

Mobile Health Application to Improve HIV Medication Adherence

HIV | Medication Adherence | Mobile Health

United States
The Miriam Hospital
National Center for Complementary and Integrative Health (NCCIH)

Completed

Health Improvement Project - Providence (HIP)

HIV

United States
The Miriam Hospital
Merck Sharp & Dohme LLC; Tufts Medical Center

Completed

Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy

HIV Infections | HIV | Hypertriglyceridemia | Hyperlipidemia

United States
Rhode Island Hospital

Completed

A Pilot Gaming Adherence Program for Youth Living With HIV

Adherence to HIV Treatment and Medication

United States
Brown University
National Center for Complementary and Integrative Health (NCCIH)

Recruiting

Developing an Online Mindfulness-based Intervention to Reduce Minority Stress and HIV Risk Among Young Adult MSM - Aim 3 (MBQR)

Hiv | Mental Health Wellness 1 | Minority Stress

United States
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)

Depression | HIV Infections | HIV

United States
VBI Vaccines Inc.

Completed

Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults

Hepatitis B Vaccines

United States, Canada, Finland, Belgium
VBI Vaccines Inc.

Completed

Lot-to-lot Consistency of Sci-B-Vac™ in Adults

Hepatitis B Vaccines

United States, United Kingdom, Finland, Belgium, Canada, Germany
Brown University
National Center for Complementary and Integrative Health (NCCIH)

Active, not recruiting

Developing an Online Mindfulness-based Intervention to Reduce Minority Stress and HIV Risk Among Young Adult MSM

HIV | Mental Health Wellness 1 | Minority Stress

United States
Butler Hospital
National Institute on Drug Abuse (NIDA)

Completed

A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

HCV Negative Status | HCV Risk Behavior

United States
Rhode Island Hospital
Emory University

Recruiting

mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV (Super SMART)

HIV | Medication Adherence | Telemedicine

United States
Amsterdam UMC, location VUmc
Boehringer Ingelheim; Abbott

Unknown

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

HIV Infections | HIV-Associated Lipodystrophy Syndrome

Finland, Netherlands, Spain, United Kingdom
National Institute of Allergy and Infectious Diseases...
Centers for Disease Control and Prevention

Completed

Rapid HIV Testing for Emergency Department Patients

HIV Infections

United States
Rhode Island Hospital

Completed

HIV Prevention for Youth With Severe Mental Illness

HIV Infections

United States
Brown University

Active, not recruiting

Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care

Alcohol Drinking | HIV

United States
Brown University
National Institute of Mental Health (NIMH)

Recruiting

Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients

HIV/AIDS

United States
National Institute on Drug Abuse (NIDA)

Completed

Motivation and Patch Treatment for HIV-positive Smokers (Positive PATHS)

HIV Infections | Smoking Cessation

United States
University of California, San Francisco

Completed

Project RAP: Family-based HIV Prevention in the Juvenile Drug Court (Project RAP)

HIV/AIDS

United States
Brown University
National Institute of Mental Health (NIMH); The University of Akron

Recruiting

Supporting Trans Affirmation, Relationships, and Sex, Phase 3 (STARS)

HIV | Violence, Domestic | Risk Reduction Behavior | Violence, Gender-Based

United States
Rhode Island Hospital

Completed

HIV, Abuse, and Psychiatric Disorders Among Youth (Project STAR)

HIV Infections

United States

Clinical Trials on HPV Vaccine in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations